Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 30, 2019 08:30 ET | Source: NewLeaf Brands Inc.

NewLeaf Brands Inc. Signs Deal With Association Partners and New Implementation Program for Up to 10,000 Retail Locations With Products to Hit Retail Shelves During the 2019 Holiday Season

VANCOUVER, British Columbia, Sept. 30, 2019 (GLOBE NEWSWIRE) -- NewLeaf Brands Inc. (CSE:NLB) (OTC: NLBIF) (FSE:0NF) (“NewLeaf Brands” or the “Company”) a health and wellness CBD company, today...
September 30, 2019 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON Presents Positive Efficacy Results on Iadademstat in ED-SCLC Patients at ESMO-2019

75% of responses in the first 8 evaluable patients treated with the triple combination of iadademstat plus carboplatin-etoposide Main toxicity of the combination is hematological Iadademstat alone is...
September 30, 2019 01:15 ET | Source: Basilea Pharmaceutica AG

Basilea berichtet auf ESMO-Meeting über klinischen Nutzen des Medikamentenkandidaten Derazantinib bei Patienten mit intrahepatischem Cholangiokarzinom (iCCA) und verschiedenen FGFR2-Genaberrationen

Basel, 30. September 2019 – Basilea Pharmaceutica AG (SIX: BSLN) berichtete heute, dass am 29. September auf der Jahrestagung der Europäischen Gesellschaft für medizinische Onkologie (ESMO) in...
September 30, 2019 01:15 ET | Source: Basilea Pharmaceutica AG

Basilea reports at ESMO meeting that drug candidate derazantinib showed clinical benefit in intrahepatic cholangiocarcinoma (iCCA) patients with various FGFR2 genetic aberrations

Basel, Switzerland, September 30, 2019 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that a post-hoc analysis of efficacy data from a previously completed phase 1/2 study with its oncology...
September 26, 2019 08:13 ET | Source: Imagin Medical Inc.

Imagin Medical Announces Meeting Regarding i/Blue’s Regulatory Pathway

VANCOUVER, British Columbia and BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
September 25, 2019 08:30 ET | Source: NewLeaf Brands Inc.

NewLeaf Brands Inc. Wholly Owned Subsidiary We Are Kured, LLC Delivers Second CBD Purchase Order to Nashville, Tennessee-Based Distribution Partner Best Strains, LLC

VANCOUVER, British Columbia, Sept. 25, 2019 (GLOBE NEWSWIRE) -- NewLeaf Brands Inc.’s (CSE:NLB) (OTC: NLBIF) (FSE:0NF) (“NewLeaf Brands” or the “Company”) wholly owned subsidiary, We Are Kured, LLC...
September 24, 2019 09:20 ET | Source: Entreprises Minières Globex Inc.

Globex conclut une entente sur le projet argentifère Bräunsdorf avec Ressources Excellon

ROUYN-NORANDA, Québec, 24 sept. 2019 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (GMX – Bourse de Toronto, G1MN – Bourses de Francfort, Stuttgart, Berlin, Munich, Tradegate, Lang &...
September 24, 2019 09:20 ET | Source: Globex Mining Enterprises Inc.

Globex Options Bräunsdorf Silver Project to Excellon Resources

ROUYN-NORANDA, Québec, Sept. 24, 2019 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang &...
September 23, 2019 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON Updates on New Activities

To present at upcoming international conference- ESMO-2019 in Barcelona, Spain- 19th Annual Biotech in Europe Investment Forum in Basel, Switzerland- 4th Annual MarketsandMarkets Epigenetics Congress...
September 10, 2019 08:00 ET | Source: Oryzon Genomics, S.A.

ORYZON Presents New Positive Efficacy Data on Vafidemstat for Treatment of Aggression

Poster presented at European College of Neuropsychopharmacology CongressShowcases efficacy data from the autism spectrum disorder (ASD) cohort of the REIMAGINE Phase IIa trialThird positive clinical...